CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Kumar Neil CEO and President | Option exercise 10b5-1 | +102,250 | 4,915,447 | ||
| 2023-08-16 | Kumar Neil CEO and President | Shares withheld for taxes 10b5-1 | −50,698 | $29.80 | $1.5M | 4,864,749 |
| 2023-08-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −5,130 | 15,388 | ||
| 2023-08-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −2,394 | 14,365 | ||
| 2023-08-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −61,182 | 122,364 | ||
| 2023-08-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −33,544 | 469,616 | ||
| 2023-07-18 | VIKING GLOBAL INVESTORS LP 10% owner | Sale | −1,500,000 | $35.00 | $52.5M | 25,120,991 |
| 2023-06-21 | Valantine Hannah Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Scott Randal W. Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Satvat Ali J. Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | MOMTAZEE JAMES C Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Lo Andrew Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | HOMCY CHARLES J Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Hassan Fred Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Ellis Andrea Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | DANIELS RONALD J Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Dachille Douglas A. Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-06-21 | AGUIAR ERIC Director | Grant or award · Stock Option (right to buy) | +51,501 | 51,501 | ||
| 2023-05-17 | Kumar Neil CEO and President | Sale 10b5-1 | −51,552 | $14.01 | $722K | 4,813,197 |
Page 29 of 32 · 638 trades